Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. - Wikidata - awgldk - TriplyDB

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.

http://www.wikidata.org/entity/Q36283611

about

CRISPR-Cas Genome Surgery in Ophthalmology.CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods.The Promise and Challenge of In Vivo Delivery for Genome Therapeutics.Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD.The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.CRISPR-mediated Ophthalmic Genome Surgery.In vivo genome editing thrives with diversified CRISPR technologies.CRISPR RNAs trigger innate immune responses in human cells.Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases.CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).In Vivo Applications of CRISPR-Based Genome Editing in the Retina.CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.CRISPR/Cas9 genome surgery for retinal diseases In Vivo Genome Editing as a Therapeutic Approach

P2860

Q33745403-603C3BA3-0D78-410E-86E3-4A444846AD34 Q38680345-7C26148D-3900-4614-BD58-E690B09A42A9 Q41430829-71C5E5F3-95A8-45B0-84D6-9DB6C4C27016 Q41919375-D8398CC7-EFEF-4A56-A0AB-EABDCCF00B6F Q42730614-6231682F-B5A4-4EC7-80E0-B7A9E5FB589E Q47299533-E4AABB1D-CEE4-4AFC-8E6C-1BA941707B33 Q47442388-4CC7C8BB-E909-4925-94DF-B872E087C7EA Q47553772-4CCCC6C1-8D14-4DD1-8E6A-C353555C9624 Q47612258-BBE1A319-C9C8-428F-9988-B6F401FE20F7 Q52363995-76860E9C-CE09-4516-86F5-D0DD91633D8E Q52374559-189EBE48-7BD0-4165-A8F8-E4C939088FE9 Q55000684-9432A996-E091-4C29-A2A1-FBB40B66C21C Q55180016-9ABFFBE2-07CC-4D6B-838A-E3A953501C4D Q55262296-BB1F52F3-5466-4DB4-A8E3-E299B6511CC0 Q55262727-F94A7EBD-91E2-4B61-BF13-9F37C1E17CCC Q55364492-94A97D46-AA2A-4DCE-AA05-88847E83D895 Q55546604-9B7B0D84-8B54-47F3-85CC-E836051128DB Q57171979-82E0A7F0-233D-4E04-AC4A-D5EAA7801903 Q58745391-E6364EB2-C0D4-4700-88FC-6B96291D9B39

P2860

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.

http://www.wikidata.org/entity/Q36283611

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@ast

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@en

type

label

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@ast

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@en

prefLabel

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@ast

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@en

P1433

Q36283611-AACDD8CF-D9F2-42AE-95EF-91ECE78CF852

P1476

Q36283611-250C976C-FE5C-47DB-9C3D-3638E09D9D68

P2093

Q36283611-0FC7374B-CCC9-4814-B57E-1B5F659CCBC4

Q36283611-1FC7A766-B357-41DF-9EF4-2269B0014C58

Q36283611-2476C8B3-B544-4D42-8579-78270B4FC6DF

Q36283611-62115DC7-2DBC-455C-8AA8-39781A457686

Q36283611-A9C1F453-9860-4729-9612-E6221C541E85

Q36283611-CDDA80CF-B32C-477C-865A-F576E0BBFD72

Q36283611-DE0E02F3-9450-44B9-BCE4-9993470AB1CE

Q36283611-ED020CC4-8BB0-4AA3-9AFC-AF30A2DD5550

P2860

Q36283611-06AF9523-8713-4A4F-99C6-3EF1AA337B38

Q36283611-093C4A2E-0EE2-46DB-8BD3-55F2A2C1B633

Q36283611-0E56DBF8-A2F0-4C11-A176-E65F052E3A49

Q36283611-1C10B0E7-7EDA-49E6-B199-BC57CD2FFF3A

Q36283611-1D9C2B65-CAD8-4C7C-94B6-DB9116DA94C4

Q36283611-1F69B81D-0C72-4E68-8E7F-8DEDDB8F4583

Q36283611-2F921E24-57D5-4E23-A504-FA95B72CA12F

Q36283611-37F37A83-0575-4E74-9FD5-41C345C8F45F

Q36283611-3C5239B5-009E-43A7-8C57-689D7273454A

Q36283611-42BA8261-B6CD-400F-8613-982F8CA4CDA5

P304

Q36283611-8CB3EEA5-6FC8-47C1-A196-212445E700CB

P31

Q36283611-453295C6-BA6C-4EA0-83E9-67155C65646E

P356

Q36283611-E632EA94-35B5-40C3-AA45-7D09B6C0349B

P433

Q36283611-D880C55B-8008-4734-A15E-C55471E2B95E

P478

Q36283611-685B8FE1-9341-46FB-81C9-1B2470D5C329

P50

Q36283611-A2C01970-0E23-4DF7-B345-8B70DE507BC9

P577

Q36283611-4788CAC9-A983-49E6-9251-105CA43A05BD

P698

Q36283611-E63CEA88-76DC-4483-9FAA-B0D25787E2AA

P921

Q36283611-7E03C4CC-55A0-4EA1-8167-3238A50AAF88

P932

Q36283611-44A29E6C-3175-4E63-9666-D5D81E014D86

P356

P1433

Genome Research

P1476

Genome surgery using Cas9 ribo ...... -related macular degeneration.

@en

P2093

Daesik Kim

http://www.w3.org/2001/XMLSchema#string

Jeong Hun Kim

http://www.w3.org/2001/XMLSchema#string

Jin Hyoung Kim

http://www.w3.org/2001/XMLSchema#string

Kwang-Eun Kim

http://www.w3.org/2001/XMLSchema#string

Kyoungmi Kim

http://www.w3.org/2001/XMLSchema#string

Seung Hwan Lee

http://www.w3.org/2001/XMLSchema#string

Sung Wook Park

http://www.w3.org/2001/XMLSchema#string

Taeyoung Koo

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system

Genome-editing Technologies for Gene and Cell Therapy

Targeted deletion of Vegfa in adult mice induces vision loss

Vascular endothelial growth factor is a secreted angiogenic mitogen

Circos: an information aesthetic for comparative genomics

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

P304

419-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GR.219089.116

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28209587

http://www.w3.org/2001/XMLSchema#string

P921

ribonucleoprotein

P932

5340969

http://www.w3.org/2001/XMLSchema#string